Levonis Bambini

Flunisolide, the active ingredient in Levonis Bambini, is a corticosteroid presented as an inhalation formulation for inhalation use. It is employed to treat inflammatory airway conditions, primarily asthma, by reducing airway swelling and hyper‑responsiveness and improving overall lung function.

GNH USA supplies Levonis Bambini as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global distribution. Our network facilitates timely delivery across Europe, Asia, Africa and the Americas, backed by robust quality‑assurance processes.

Flunisolide, an inhaled corticosteroid, acts on airway inflammation in asthma.

- Asthma (mild persistent): improves daily symptom control and reduces need for rescue inhaler. - Asthma (moderate persistent): decreases frequency of exacerbations and hospital visits. - Asthma (severe persistent): contributes to long‑term lung function preservation when used as maintenance therapy.

Common Side Effects: - Oral candidiasis (thrush) due to local immunosuppression. - Hoarseness or voice changes. - Cough or throat irritation after inhalation. - Mild headache. - Nausea. - Upper respiratory tract infection.

Serious or Rare Side Effects: - Adrenal suppression with systemic effects. - Growth retardation in children with prolonged use. - Severe allergic reactions, including anaphylaxis. - Pneumonia or other serious respiratory infections. - Cataracts or glaucoma with long‑term therapy. - Paradoxical bronchospasm.

Before initiating therapy, assess asthma control and educate patients on proper inhaler technique.

- Monitor for oral thrush: advise rinsing mouth after each dose. - Use a spacer device to minimize oropharyngeal deposition. - Avoid abrupt discontinuation; taper if long‑term high doses are used. - Caution in patients with active tuberculosis or untreated infections. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at room temperature: keep in the original container, protect from moisture and light.

Flunisolide may interact with several medications that affect corticosteroid activity or immune response.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin): may reduce inhaled steroid efficacy. - Systemic corticosteroids: increase risk of systemic side effects. - Live vaccines: may suppress vaccine‑induced immunity.

Moderate Interactions (Monitor Closely): - Short‑acting β2‑agonists: may mask worsening asthma symptoms. - Antifungal agents (e.g., ketoconazole): may increase local exposure. - Diuretics: potential electrolyte disturbances. - Anticholinergics: additive bronchodilatory effects.